Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients. Read more about Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells. Read more about Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease. Read more about Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease.
How I individualize treatment for chronic-phase CML. Read more about How I individualize treatment for chronic-phase CML.
Decoding functional hematopoietic progenitor cells in the adult human lung. Read more about Decoding functional hematopoietic progenitor cells in the adult human lung.
Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies. Read more about Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.
The promise of allosteric kinase inhibition. Read more about The promise of allosteric kinase inhibition.
Pediatric Autoimmune Hemolytic Anemia Is Associated with a High Incidence of an Underlying Immune Disorder and High Mortality Rate. Read more about Pediatric Autoimmune Hemolytic Anemia Is Associated with a High Incidence of an Underlying Immune Disorder and High Mortality Rate.
Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children. Read more about Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children.
Association between Sleep Traits and Risk of Non-Hodgkin's Lymphoma Subtypes: A Mendelian Randomization Study in the International Lymphoma (InterLymph) Epidemiology Consortium. Read more about Association between Sleep Traits and Risk of Non-Hodgkin's Lymphoma Subtypes: A Mendelian Randomization Study in the International Lymphoma (InterLymph) Epidemiology Consortium.
